
Keywords: 4 HPR; DENV; dengue virus; DF; dengue fever; DHF; dengue hemorrhagic fever; DSS; dengue shock syndrome; ADE; antibody-dependent enhancement; HCV; hepatitis C virus; HTS; high-throughput screening; TNFα; tumor necrosis factor α; IFN; interferon; MCP-1; monocyte